HomeCompareMDT vs SLB

MDT vs SLB: Dividend Comparison 2026

MDT yields 3.31% · SLB yields 2.23%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MDT wins by $32.9K in total portfolio value
10 years
MDT
MDT
● Live price
3.31%
Share price
$85.74
Annual div
$2.84
5Y div CAGR
29.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$54.3K
Annual income
$9,789.15
Full MDT calculator →
SLB
SLB
● Live price
2.23%
Share price
$51.53
Annual div
$1.15
5Y div CAGR
-12.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$62.32
Full SLB calculator →

Portfolio growth — MDT vs SLB

📍 MDT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMDTSLB
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MDT + SLB cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MDT pays
SLB pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MDT
Annual income on $10K today (after 15% tax)
$281.55/yr
After 10yr DRIP, annual income (after tax)
$8,320.78/yr
SLB
Annual income on $10K today (after 15% tax)
$189.70/yr
After 10yr DRIP, annual income (after tax)
$52.97/yr
At 15% tax rate, MDT beats the other by $8,267.81/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MDT + SLB for your $10,000?

MDT: 50%SLB: 50%
100% SLB50/50100% MDT
Portfolio after 10yr
$37.9K
Annual income
$4,925.74/yr
Blended yield
13.01%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SLB right now

MDT
Analyst Ratings
1
Strong
26
Buy
22
Hold
Consensus: Buy
Price Target
$111.45
+30.0% upside vs current
Range: $100.00 — $120.00
Altman Z
2.9
Piotroski
7/9
SLB
Analyst Ratings
56
Buy
6
Hold
4
Sell
Consensus: Buy
Price Target
$52.95
+2.8% upside vs current
Range: $45.00 — $61.00
Altman Z
3.2
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MDT buys
0
SLB buys
0
No recent congressional trades found for MDT or SLB in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMDTSLB
Forward yield3.31%2.23%
Annual dividend / share$2.84$1.15
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR29.3%-12.7%
Portfolio after 10y$54.3K$21.4K
Annual income after 10y$9,789.15$62.32
Total dividends collected$29.9K$1.2K
Payment frequencyquarterlyquarterly
SectorHealthcareEnergy
Analyst consensusBuyBuy
Analyst price target$111.45$52.95

Year-by-year: MDT vs SLB ($10,000, DRIP)

YearMDT PortfolioMDT Income/yrSLB PortfolioSLB Income/yrGap
1← crossover$11,128$428.29$10,895$194.83+$233.00MDT
2$12,483$575.94$11,831$173.18+$652.00MDT
3$14,138$780.71$12,812$153.43+$1.3KMDT
4$16,196$1,068.46$13,845$135.57+$2.4KMDT
5$18,809$1,479.09$14,933$119.52+$3.9KMDT
6$22,201$2,075.70$16,084$105.19+$6.1KMDT
7$26,716$2,960.69$17,302$92.43+$9.4KMDT
8$32,891$4,305.30$18,594$81.13+$14.3KMDT
9$41,599$6,405.16$19,967$71.13+$21.6KMDT
10$54,300$9,789.15$21,427$62.32+$32.9KMDT

MDT vs SLB: Complete Analysis 2026

MDTHealthcare

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Full MDT Calculator →

SLBEnergy

SLB N.V. engages in the provision of technology for the energy industry worldwide. The company operates through four divisions: Digital & Integration, Reservoir Performance, Well Construction, and Production Systems. The company provides field development and hydrocarbon production, carbon management, and integration of adjacent energy systems; reservoir interpretation and data processing services for exploration data; and well construction and production improvement services and products. It also offers subsurface geology and fluids evaluation information; stimulation services to restore or enhance well productivity through hydraulic fracturing, matrix stimulation, and water treatment; and intervention services to oil and gas operators. In addition, the company offers mud logging, directional drilling, measurement-while-drilling, and logging-while-drilling services, as well as engineering support services; supplies drilling fluid systems; designs, manufactures, and markets roller cone and fixed cutter drill bits; bottom-hole-assembly and borehole enlargement technologies; well planning, well drilling, engineering, supervision, logistics, procurement, and contracting of third parties, as well as drilling rig management solutions; and drilling equipment and services, as well as land drilling rigs and related services. Further, it provides artificial lift; supplies packers, safety valves, sand control technology, and various intelligent systems; midstream production systems; valves, chokes, actuators, and surface trees; and OneSubsea, an integrated solutions, products, systems, and services, including wellheads, subsea trees, manifolds and flowline connectors, control systems, connectors, and services. The company was formerly known as Schlumberger Limited and change its name to SLB N.V. in October 2025. SLB N.V. was founded in 1926 and is based in Houston, Texas.

Full SLB Calculator →
📬

Get this MDT vs SLB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MDT vs SCHDMDT vs JEPIMDT vs OMDT vs KOMDT vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.